Analysis of the plasma proteome in COPD: Novel low abundance proteins reflect the severity of lung remodeling.

Analysis of the plasma proteome in COPD: Novel low abundance proteins reflect the severity of lung remodeling.
复制标题

DOI:
10.3109/15412555.2013.831063
复制
发表时间:
2014-04
期刊:
影响因子:
2.2
通讯作者:
Kelsen SG
Kelsen SG
中科院分区:
医学4区
文献类型:
--
作者:
Merali S;Barrero CA;Bowler RP;Chen DE;Criner G;Braverman A;Litwin S;Yeung A;Kelsen SG

文献摘要

参考文献

被引文献

相似文献

The search for COPD biomarkers has largely employed a targeted approach that focuses on plasma proteins involved in the systemic inflammatory response and in lung injury and repair. This proof of concept study was designed to test the idea that an open, unbiased, in-depth proteomics approach could identify novel, low abundance plasma proteins i.e., ng/mL concentration, which could serve as potential biomarkers. Differentially expressed proteins were identified in a discovery group with severe COPD (FEV1 <45% predicted; n = 10). Subjects with normal lung function matched for age, sex, ethnicity and smoking history served as controls (n = 10). Pooled plasma from each group was exhaustively immunodepleted of abundant proteins, d separated by 1-D gel electrophoresis and extensively fractionated prior to LC-tandem mass spectroscopy (GeLC-MS). Thirty one differentially expressed proteins were identified in the discovery group including markers of lung defense against oxidant stress, alveolar macrophage activation, and lung tissue injury and repair. Four of the 31 proteins (i.e., GRP78, soluble CD163, IL1AP and MSPT9) were measured in a separate verification group of 80 subjects with varying COPD severity by immunoassay. All 4 were significantly altered in COPD and 2 (GRP78 and soluble CD163) correlated with both FEV1 and the extent of emphysema. In-depth, plasma proteomic analysis identified a group of novel, differentially expressed, low abundance proteins that reflect known pathogenic mechanisms and the severity of lung remodeling in COPD. These proteins may also prove useful as COPD biomarkers.
DOI: 10.1073/pnas.1107559108
发表时间: 2011-06-28
影响因子: 11.1
作者:
Lawson, William E.;Cheng, Dong-Sheng;Blackwell, Timothy S.
通讯作者: Blackwell, Timothy S.
DOI: 10.1021/pr070233q
发表时间: 2007-09-01
影响因子: 4.4
作者:
Faca, Vitor;Pitteri, Sharon J.;Hanash, Samir
通讯作者: Hanash, Samir
DOI: 10.1021/pr901063t
发表时间: 2010-04-01
影响因子: 4.4
作者:
Fang, Yuan;Robinson, Dale P.;Foster, Leonard J.
通讯作者: Foster, Leonard J.
DOI: 10.1183/09031936.00160007
发表时间: 2008-10-01
影响因子: 24.3
作者:
Godtfredsen, N. S.;Lam, T. H.;Vestbo, J.
通讯作者: Vestbo, J.
DOI: 10.1165/rcmb.2007-0221oc
发表时间: 2008-05-01
影响因子: 6.4
作者:
Kelsen, Steven G.;Duan, Xunbao;Merali, Salim
通讯作者: Merali, Salim